Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAF
|
ENSG00000178573.6 | MAF bZIP transcription factor |
NRL
|
ENSG00000129535.8 | neural retina leucine zipper |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MAF | hg19_v2_chr16_-_79633799_79633872 | -0.13 | 4.9e-01 | Click! |
NRL | hg19_v2_chr14_-_24553834_24553850 | -0.08 | 6.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_57431679 | 6.95 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
chr11_+_116700600 | 6.02 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
chr11_+_116700614 | 5.97 |
ENST00000375345.1
|
APOC3
|
apolipoprotein C-III |
chr5_-_156390230 | 4.67 |
ENST00000407087.3
ENST00000274532.2 |
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4 |
chr22_+_21128167 | 3.71 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr1_+_233749739 | 3.24 |
ENST00000366621.3
|
KCNK1
|
potassium channel, subfamily K, member 1 |
chr9_-_116840728 | 2.87 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr10_+_96443378 | 2.79 |
ENST00000285979.6
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
chr14_-_106237742 | 2.79 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr22_+_22712087 | 2.71 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr2_-_89385283 | 2.50 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr4_+_100495864 | 2.32 |
ENST00000265517.5
ENST00000422897.2 |
MTTP
|
microsomal triglyceride transfer protein |
chr1_-_201368653 | 2.32 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr10_+_96443204 | 2.29 |
ENST00000339022.5
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
chr21_+_44589118 | 2.16 |
ENST00000291554.2
|
CRYAA
|
crystallin, alpha A |
chr1_-_201368707 | 2.13 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr2_+_90458201 | 2.10 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
chr2_-_89568263 | 2.08 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr17_+_41052808 | 2.07 |
ENST00000592383.1
ENST00000253801.2 ENST00000585489.1 |
G6PC
|
glucose-6-phosphatase, catalytic subunit |
chr14_-_106114739 | 2.01 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
chr22_+_22385332 | 2.00 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr16_+_32859034 | 1.95 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
chr9_+_139839686 | 1.90 |
ENST00000371634.2
|
C8G
|
complement component 8, gamma polypeptide |
chr20_+_45338126 | 1.90 |
ENST00000359271.2
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10 |
chr12_-_53297432 | 1.86 |
ENST00000546900.1
|
KRT8
|
keratin 8 |
chr1_-_157811588 | 1.86 |
ENST00000368174.4
|
CD5L
|
CD5 molecule-like |
chr3_+_184097836 | 1.85 |
ENST00000204604.1
ENST00000310236.3 |
CHRD
|
chordin |
chr3_-_50340996 | 1.83 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr3_+_184097905 | 1.82 |
ENST00000450923.1
|
CHRD
|
chordin |
chr11_-_2924720 | 1.80 |
ENST00000455942.2
|
SLC22A18AS
|
solute carrier family 22 (organic cation transporter), member 18 antisense |
chr11_+_77774897 | 1.79 |
ENST00000281030.2
|
THRSP
|
thyroid hormone responsive |
chr3_+_184098065 | 1.79 |
ENST00000348986.3
|
CHRD
|
chordin |
chr2_-_20425158 | 1.78 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
chr2_+_234600253 | 1.78 |
ENST00000373424.1
ENST00000441351.1 |
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6 |
chr18_+_29171689 | 1.77 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr4_+_42399856 | 1.71 |
ENST00000319234.4
|
SHISA3
|
shisa family member 3 |
chr20_-_48099182 | 1.67 |
ENST00000371741.4
|
KCNB1
|
potassium voltage-gated channel, Shab-related subfamily, member 1 |
chr6_+_31895467 | 1.66 |
ENST00000556679.1
ENST00000456570.1 |
CFB
CFB
|
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr22_+_22516550 | 1.65 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr17_-_54893250 | 1.63 |
ENST00000397862.2
|
C17orf67
|
chromosome 17 open reading frame 67 |
chr19_+_45417921 | 1.61 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
chr19_+_45417504 | 1.61 |
ENST00000588750.1
ENST00000588802.1 |
APOC1
|
apolipoprotein C-I |
chr19_+_45418067 | 1.58 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr22_+_23222886 | 1.58 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr2_-_188419078 | 1.57 |
ENST00000437725.1
ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr9_+_27109392 | 1.56 |
ENST00000406359.4
|
TEK
|
TEK tyrosine kinase, endothelial |
chr22_+_22730353 | 1.54 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr20_+_36974759 | 1.53 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
chr2_-_188419200 | 1.53 |
ENST00000233156.3
ENST00000426055.1 ENST00000453013.1 ENST00000417013.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr18_-_25616519 | 1.51 |
ENST00000399380.3
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal) |
chr20_-_22559211 | 1.48 |
ENST00000564492.1
|
LINC00261
|
long intergenic non-protein coding RNA 261 |
chr2_+_89184868 | 1.46 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr3_+_52828805 | 1.43 |
ENST00000416872.2
ENST00000449956.2 |
ITIH3
|
inter-alpha-trypsin inhibitor heavy chain 3 |
chrX_+_123480375 | 1.42 |
ENST00000360027.4
|
SH2D1A
|
SH2 domain containing 1A |
chr6_+_143381979 | 1.41 |
ENST00000367598.5
ENST00000447498.1 ENST00000357847.4 ENST00000344492.5 ENST00000367596.1 ENST00000494282.2 ENST00000275235.4 |
AIG1
|
androgen-induced 1 |
chr5_+_1201703 | 1.41 |
ENST00000304460.10
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19 |
chr14_-_107179265 | 1.41 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
chr2_+_120187465 | 1.40 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
chr9_+_27109440 | 1.37 |
ENST00000519080.1
|
TEK
|
TEK tyrosine kinase, endothelial |
chr16_+_57438679 | 1.36 |
ENST00000219244.4
|
CCL17
|
chemokine (C-C motif) ligand 17 |
chr7_-_14028488 | 1.36 |
ENST00000405358.4
|
ETV1
|
ets variant 1 |
chrX_+_123480194 | 1.35 |
ENST00000371139.4
|
SH2D1A
|
SH2 domain containing 1A |
chr12_-_102874330 | 1.32 |
ENST00000307046.8
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr2_+_231902193 | 1.30 |
ENST00000373640.4
|
C2orf72
|
chromosome 2 open reading frame 72 |
chr19_-_7812446 | 1.30 |
ENST00000394173.4
ENST00000301357.8 |
CD209
|
CD209 molecule |
chr12_+_103981044 | 1.30 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr3_+_186330712 | 1.27 |
ENST00000411641.2
ENST00000273784.5 |
AHSG
|
alpha-2-HS-glycoprotein |
chr6_+_31895480 | 1.26 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
C2
CFB
|
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr6_+_31895254 | 1.24 |
ENST00000299367.5
ENST00000442278.2 |
C2
|
complement component 2 |
chr19_+_45417812 | 1.24 |
ENST00000592535.1
|
APOC1
|
apolipoprotein C-I |
chr2_+_128180842 | 1.23 |
ENST00000402125.2
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
chr5_+_42756903 | 1.22 |
ENST00000361970.5
ENST00000388827.4 |
CCDC152
|
coiled-coil domain containing 152 |
chr10_+_96522361 | 1.21 |
ENST00000371321.3
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19 |
chr11_-_57004658 | 1.21 |
ENST00000606794.1
|
APLNR
|
apelin receptor |
chr12_-_102874102 | 1.20 |
ENST00000392905.2
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr22_+_23154239 | 1.19 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr6_+_32006042 | 1.19 |
ENST00000418967.2
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
chr2_+_90273679 | 1.18 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr22_+_22681656 | 1.18 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr14_-_106092403 | 1.17 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr19_-_46476791 | 1.16 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
chr11_+_22688150 | 1.16 |
ENST00000454584.2
|
GAS2
|
growth arrest-specific 2 |
chr22_+_22697537 | 1.14 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr22_+_22735135 | 1.14 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr22_+_23029188 | 1.13 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr17_-_73874654 | 1.12 |
ENST00000254816.2
|
TRIM47
|
tripartite motif containing 47 |
chr11_+_74862140 | 1.12 |
ENST00000525650.1
ENST00000454962.2 |
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1 |
chr2_+_234637754 | 1.12 |
ENST00000482026.1
ENST00000609767.1 |
UGT1A3
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A3 UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr4_+_111397216 | 1.11 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
chr6_+_31895287 | 1.10 |
ENST00000447952.2
|
C2
|
complement component 2 |
chr10_-_44880491 | 1.10 |
ENST00000374426.2
ENST00000395795.4 ENST00000395794.2 ENST00000374429.2 ENST00000395793.3 ENST00000343575.6 |
CXCL12
|
chemokine (C-X-C motif) ligand 12 |
chr9_+_27109133 | 1.09 |
ENST00000519097.1
ENST00000380036.4 |
TEK
|
TEK tyrosine kinase, endothelial |
chr20_+_34203794 | 1.09 |
ENST00000374273.3
|
SPAG4
|
sperm associated antigen 4 |
chr19_-_55895966 | 1.08 |
ENST00000444469.3
|
TMEM238
|
transmembrane protein 238 |
chr14_-_106406090 | 1.08 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr7_-_100239132 | 1.07 |
ENST00000223051.3
ENST00000431692.1 |
TFR2
|
transferrin receptor 2 |
chr7_-_99332719 | 1.07 |
ENST00000336374.2
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7 |
chr22_+_22764088 | 1.07 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr6_+_32006159 | 1.04 |
ENST00000478281.1
ENST00000471671.1 ENST00000435122.2 |
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
chr12_+_52626898 | 1.04 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
chr6_+_50061315 | 1.03 |
ENST00000415106.1
|
RP11-397G17.1
|
RP11-397G17.1 |
chr2_-_190044480 | 1.03 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr14_-_106692191 | 1.01 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr14_-_106878083 | 1.00 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr11_-_116708302 | 1.00 |
ENST00000375320.1
ENST00000359492.2 ENST00000375329.2 ENST00000375323.1 |
APOA1
|
apolipoprotein A-I |
chr3_-_88108192 | 0.99 |
ENST00000309534.6
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
chrX_-_47479246 | 0.99 |
ENST00000295987.7
ENST00000340666.4 |
SYN1
|
synapsin I |
chr11_-_10590118 | 0.99 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr22_+_22930626 | 0.99 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr11_-_10590238 | 0.99 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr11_-_2182388 | 0.98 |
ENST00000421783.1
ENST00000397262.1 ENST00000250971.3 ENST00000381330.4 ENST00000397270.1 |
INS
INS-IGF2
|
insulin INS-IGF2 readthrough |
chr22_+_22786288 | 0.98 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr2_-_89513402 | 0.98 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr9_-_112260531 | 0.97 |
ENST00000374541.2
ENST00000262539.3 |
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
chr3_-_88108212 | 0.97 |
ENST00000482016.1
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
chr3_+_50192499 | 0.96 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr2_+_113885138 | 0.96 |
ENST00000409930.3
|
IL1RN
|
interleukin 1 receptor antagonist |
chr4_-_57976544 | 0.95 |
ENST00000295666.4
ENST00000537922.1 |
IGFBP7
|
insulin-like growth factor binding protein 7 |
chr1_+_171283331 | 0.94 |
ENST00000367749.3
|
FMO4
|
flavin containing monooxygenase 4 |
chr2_-_151344172 | 0.93 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr2_+_135596106 | 0.92 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr19_-_58864848 | 0.92 |
ENST00000263100.3
|
A1BG
|
alpha-1-B glycoprotein |
chr2_+_135596180 | 0.91 |
ENST00000283054.4
ENST00000392928.1 |
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr14_+_69865401 | 0.91 |
ENST00000556605.1
ENST00000336643.5 ENST00000031146.4 |
SLC39A9
|
solute carrier family 39, member 9 |
chr22_+_23235872 | 0.91 |
ENST00000390320.2
|
IGLJ1
|
immunoglobulin lambda joining 1 |
chr11_+_22688615 | 0.91 |
ENST00000533363.1
|
GAS2
|
growth arrest-specific 2 |
chr22_+_22676808 | 0.91 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr12_-_14996355 | 0.90 |
ENST00000228936.4
|
ART4
|
ADP-ribosyltransferase 4 (Dombrock blood group) |
chr3_+_50192457 | 0.89 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr14_-_23058063 | 0.88 |
ENST00000538631.1
ENST00000543337.1 ENST00000250498.4 |
DAD1
|
defender against cell death 1 |
chr3_+_185080908 | 0.87 |
ENST00000265026.3
|
MAP3K13
|
mitogen-activated protein kinase kinase kinase 13 |
chr12_+_2079939 | 0.86 |
ENST00000543114.1
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
chr6_-_25930819 | 0.84 |
ENST00000360488.3
|
SLC17A2
|
solute carrier family 17, member 2 |
chr19_-_7812397 | 0.84 |
ENST00000593660.1
ENST00000354397.6 ENST00000593821.1 ENST00000602261.1 ENST00000315591.8 ENST00000394161.5 ENST00000204801.8 ENST00000601256.1 ENST00000601951.1 ENST00000315599.7 |
CD209
|
CD209 molecule |
chr8_+_80523321 | 0.84 |
ENST00000518111.1
|
STMN2
|
stathmin-like 2 |
chr21_-_40033618 | 0.83 |
ENST00000417133.2
ENST00000398910.1 ENST00000442448.1 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr2_-_74757066 | 0.83 |
ENST00000377526.3
|
AUP1
|
ancient ubiquitous protein 1 |
chrX_+_17755696 | 0.83 |
ENST00000419185.1
|
SCML1
|
sex comb on midleg-like 1 (Drosophila) |
chr11_-_914774 | 0.83 |
ENST00000528154.1
ENST00000525840.1 |
CHID1
|
chitinase domain containing 1 |
chr18_-_5197501 | 0.82 |
ENST00000580650.1
|
C18orf42
|
chromosome 18 open reading frame 42 |
chr9_+_139746792 | 0.81 |
ENST00000317446.2
ENST00000445819.1 |
MAMDC4
|
MAM domain containing 4 |
chrX_+_128913906 | 0.81 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr10_+_115312825 | 0.81 |
ENST00000537906.1
ENST00000541666.1 |
HABP2
|
hyaluronan binding protein 2 |
chr11_-_2160180 | 0.81 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr14_-_106866934 | 0.81 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
chr17_+_27573875 | 0.80 |
ENST00000225387.3
|
CRYBA1
|
crystallin, beta A1 |
chr3_+_100328433 | 0.80 |
ENST00000273352.3
|
GPR128
|
G protein-coupled receptor 128 |
chr14_-_106518922 | 0.80 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
chr6_-_25930904 | 0.79 |
ENST00000377850.3
|
SLC17A2
|
solute carrier family 17, member 2 |
chr9_-_128003606 | 0.78 |
ENST00000324460.6
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
chr22_+_22749343 | 0.78 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr12_-_102874416 | 0.78 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr14_-_106791536 | 0.77 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr14_-_107199464 | 0.76 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
chr17_-_38520067 | 0.76 |
ENST00000337376.4
ENST00000578689.1 |
GJD3
|
gap junction protein, delta 3, 31.9kDa |
chr21_-_45671014 | 0.75 |
ENST00000436357.1
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like |
chr20_+_42187682 | 0.75 |
ENST00000373092.3
ENST00000373077.1 |
SGK2
|
serum/glucocorticoid regulated kinase 2 |
chr11_-_12030905 | 0.75 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr9_-_13175823 | 0.75 |
ENST00000545857.1
|
MPDZ
|
multiple PDZ domain protein |
chr18_-_64271363 | 0.74 |
ENST00000262150.2
|
CDH19
|
cadherin 19, type 2 |
chr22_+_25595817 | 0.74 |
ENST00000215855.2
ENST00000404334.1 |
CRYBB3
|
crystallin, beta B3 |
chr15_-_40212363 | 0.73 |
ENST00000299092.3
|
GPR176
|
G protein-coupled receptor 176 |
chr11_+_101983176 | 0.73 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr4_+_154125565 | 0.73 |
ENST00000338700.5
|
TRIM2
|
tripartite motif containing 2 |
chr16_-_28518153 | 0.72 |
ENST00000356897.1
|
IL27
|
interleukin 27 |
chr13_+_93879085 | 0.72 |
ENST00000377047.4
|
GPC6
|
glypican 6 |
chr6_-_138866823 | 0.71 |
ENST00000342260.5
|
NHSL1
|
NHS-like 1 |
chr7_-_41742697 | 0.71 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr7_-_94285472 | 0.71 |
ENST00000437425.2
ENST00000447873.1 ENST00000415788.2 |
SGCE
|
sarcoglycan, epsilon |
chr7_-_8302298 | 0.71 |
ENST00000446305.1
|
ICA1
|
islet cell autoantigen 1, 69kDa |
chr7_+_26331541 | 0.70 |
ENST00000416246.1
ENST00000338523.4 ENST00000412416.1 |
SNX10
|
sorting nexin 10 |
chr10_-_50970322 | 0.70 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
chr12_+_56075330 | 0.70 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
chr7_+_65540853 | 0.70 |
ENST00000380839.4
ENST00000395332.3 ENST00000362000.5 ENST00000395331.3 |
ASL
|
argininosuccinate lyase |
chr1_-_119869846 | 0.69 |
ENST00000457719.1
|
RP11-418J17.3
|
RP11-418J17.3 |
chr5_+_63802109 | 0.69 |
ENST00000334025.2
|
RGS7BP
|
regulator of G-protein signaling 7 binding protein |
chr4_+_39408470 | 0.69 |
ENST00000257408.4
|
KLB
|
klotho beta |
chrX_+_17755563 | 0.69 |
ENST00000380045.3
ENST00000380041.3 ENST00000380043.3 ENST00000398080.1 |
SCML1
|
sex comb on midleg-like 1 (Drosophila) |
chr10_-_98031265 | 0.68 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
chr3_+_38388251 | 0.68 |
ENST00000427323.1
ENST00000207870.3 ENST00000542835.1 |
XYLB
|
xylulokinase homolog (H. influenzae) |
chr16_-_28550348 | 0.68 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr5_-_138718973 | 0.67 |
ENST00000353963.3
ENST00000348729.3 |
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1 |
chr6_-_24489842 | 0.67 |
ENST00000230036.1
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1 |
chr15_+_96875657 | 0.67 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr1_+_61869748 | 0.65 |
ENST00000357977.5
|
NFIA
|
nuclear factor I/A |
chr12_-_102874378 | 0.65 |
ENST00000456098.1
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr11_-_2924970 | 0.65 |
ENST00000533594.1
|
SLC22A18AS
|
solute carrier family 22 (organic cation transporter), member 18 antisense |
chr16_+_777739 | 0.64 |
ENST00000563792.1
|
HAGHL
|
hydroxyacylglutathione hydrolase-like |
chr12_-_92539614 | 0.64 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr3_+_50192537 | 0.64 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr22_-_38240412 | 0.63 |
ENST00000215941.4
|
ANKRD54
|
ankyrin repeat domain 54 |
chr16_+_226658 | 0.63 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr7_-_8301869 | 0.63 |
ENST00000402384.3
|
ICA1
|
islet cell autoantigen 1, 69kDa |
chr16_+_2510081 | 0.62 |
ENST00000361837.4
ENST00000569496.1 ENST00000567489.1 ENST00000563531.1 ENST00000483320.1 |
C16orf59
|
chromosome 16 open reading frame 59 |
chr8_+_30244580 | 0.62 |
ENST00000523115.1
ENST00000519647.1 |
RBPMS
|
RNA binding protein with multiple splicing |
chr17_-_56494882 | 0.62 |
ENST00000584437.1
|
RNF43
|
ring finger protein 43 |
chr17_+_41003166 | 0.62 |
ENST00000308423.2
|
AOC3
|
amine oxidase, copper containing 3 |
chr7_-_128415844 | 0.62 |
ENST00000249389.2
|
OPN1SW
|
opsin 1 (cone pigments), short-wave-sensitive |
chr1_-_160832642 | 0.61 |
ENST00000368034.4
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr6_-_133035185 | 0.61 |
ENST00000367928.4
|
VNN1
|
vanin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 12.0 | GO:0060621 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
1.8 | 5.5 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
1.5 | 6.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.0 | 1.0 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.8 | 3.9 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.6 | 1.8 | GO:0048627 | myoblast development(GO:0048627) |
0.5 | 3.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 1.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 1.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.5 | 3.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 11.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 2.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.4 | 1.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.4 | 3.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.4 | 1.8 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 1.0 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) glomerular endothelium development(GO:0072011) |
0.3 | 1.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.3 | 1.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.3 | 1.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 3.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 4.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 1.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 0.8 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 1.8 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 0.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 6.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.7 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 1.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 1.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.2 | 0.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 2.9 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.2 | 0.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.2 | 31.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 1.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.2 | 2.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.2 | 0.6 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.2 | 0.7 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.2 | 1.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 2.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 1.2 | GO:0001554 | luteolysis(GO:0001554) |
0.2 | 0.7 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.2 | 0.7 | GO:0009956 | radial pattern formation(GO:0009956) |
0.2 | 0.5 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.2 | 3.4 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.2 | 2.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.6 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 1.1 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.1 | 1.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.9 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.4 | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) |
0.1 | 0.9 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.5 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.1 | 0.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.4 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.1 | 1.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.5 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.4 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.4 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 1.3 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.5 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.3 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 1.9 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.0 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 1.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.3 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 0.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.3 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 3.1 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.6 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 1.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 2.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 1.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 0.2 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 1.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.3 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 2.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.4 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.6 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 0.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.1 | 1.8 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.1 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.3 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.1 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.8 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.5 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 1.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.1 | 0.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.1 | 0.4 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 12.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.4 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.1 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.2 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.3 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.3 | GO:0035567 | establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) non-canonical Wnt signaling pathway(GO:0035567) |
0.1 | 0.2 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.5 | GO:0035768 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.1 | 0.6 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 2.4 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.8 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 1.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 1.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 1.9 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.0 | 1.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.2 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.0 | 0.1 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.0 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.0 | 0.1 | GO:1900673 | cellular alkene metabolic process(GO:0043449) olefin metabolic process(GO:1900673) |
0.0 | 0.3 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.1 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.1 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.0 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.9 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.2 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.0 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 1.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 1.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.2 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.0 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.2 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 1.7 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.2 | GO:0030208 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.0 | 0.3 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.3 | GO:0007519 | skeletal muscle tissue development(GO:0007519) skeletal muscle organ development(GO:0060538) |
0.0 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 1.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 1.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.3 | GO:1901374 | acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) negative regulation of natural killer cell cytokine production(GO:0002728) |
0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.0 | 0.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.0 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 1.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 1.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.0 | 0.0 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
0.0 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.2 | GO:1903206 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.0 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.6 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.0 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.4 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 13.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.9 | 8.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 3.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.6 | 1.8 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.4 | 3.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 6.4 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.7 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 10.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.8 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 1.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.6 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.3 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.1 | 1.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 1.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 1.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 6.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 18.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.1 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 3.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.3 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.3 | GO:0070701 | mucus layer(GO:0070701) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.0 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 1.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 6.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.7 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 4.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 4.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 1.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.2 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 34.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 1.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 1.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 1.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 1.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 13.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 6.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.7 | 2.9 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 5.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 2.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 1.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.4 | 1.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 6.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 1.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 0.9 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 0.7 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.2 | 2.1 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.6 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.2 | 1.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.5 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.2 | 1.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 1.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.6 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 9.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 3.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 3.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 4.8 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 28.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.4 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.4 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 6.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 3.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 2.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.9 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.6 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.7 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 3.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.1 | 0.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 2.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 9.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 4.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 1.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 1.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.4 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 1.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 1.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 1.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 3.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 3.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 1.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 2.3 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.0 | 1.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 1.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 3.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 1.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.0 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 1.0 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.0 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.0 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 3.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 8.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 6.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 4.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 6.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 3.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 3.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 4.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 1.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 2.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 10.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.9 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 17.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 7.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 14.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 4.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 3.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 4.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 3.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 2.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 2.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 2.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 2.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |